Changing the Course of Schizophrenia--Predictors of Treatment Outcome Revisited‪.‬

Multiple factors play a role in determining the outcome of schizophrenia. However, the role of these factors is poorly understood, and research findings so far have been inconclusive and sometimes contradictory. Various demographic and baseline clinical factors have been reported to be associated with treatment outcome. Also, early symptom reduction after initiation of antipsychotic therapy is closely related to later treatment response. However, associations as such do not necessarily imply predictive value, and none of these factors can be regarded as clinically useful in predicting treatment outcome. This article discusses selected aspects of treatment outcome and its prediction in schizophrenia, focusing particularly on early treatment response, ethnicity, neurological soft signs, and the predictive value of a discriminant functional analysis model utilising a combination of putative predictors. Such a model holds promise, and it is to be hoped that future refinements will lead to a clinically useful model for predicting outcome. Schizophrenia is an incapacitating brain disease, having been described as arguably the worst illness affecting humankind--costly in personal, social and financial terms. (1) It imposes a disproportionately large economic burden on patients and their families, health care systems and society, because of its early onset, devastating effects, and usually lifelong course. (2)